| Compounds, compositions and methods |
2022-12-28 |
2023-4-11 |
|
| Compounds, compositions and methods |
2022-9-16 |
2023-3-23 |
|
| Compounds, compositions and methods |
2022-9-07 |
2022-11-22 |
|
| Anti-her2 antibodies and methods of use thereof |
2022-8-25 |
2023-3-02 |
|
| Engineered anti-her2 bispecific proteins |
2022-8-25 |
2023-3-16 |
|
| Engineered anti-her2 bispecific proteins, compositions comprising same and uses … |
2022-8-17 |
2022-10-01 |
|
| Compounds, compositions and methods |
2022-7-29 |
2022-10-12 |
|
| Methods for the treatment of hunter syndrome |
2022-7-22 |
2023-1-26 |
|
| Compounds, compositions and methods |
2022-7-15 |
2023-1-19 |
|
| ANTI-TREM2 ANTIBODIES AND METHODS TO USE THEM |
2022-7-12 |
2022-8-31 |
|
| Anti-trem2 antibodies and methods of using them |
2022-7-12 |
2022-7-19 |
|
| Oligonucleotide conjugates targeted to the transferrin receptor |
2022-7-01 |
2023-1-05 |
|
| Fusion proteins comprising sulfoglucosamine sulfohydrolase enzymes and methods … |
2022-6-30 |
2023-3-02 |
|
| Progranulin variants |
2022-6-21 |
2022-6-30 |
|
| PROGRANULIN VARIANTS |
2022-6-21 |
2022-7-29 |
|
| Compounds, compositions, and methods |
2022-4-29 |
2022-11-03 |
|
| Methods for treating and monitoring parkinson's disease |
2022-4-29 |
2022-11-03 |
|
| Pyrimidin-2-ylamino-1H-pyrazols as LRRK2 inhibitors for use in the treatment of … |
2022-4-08 |
2022-4-28 |
|
| Compounds, compositions and methods |
2022-3-23 |
2023-4-13 |
|
| Anti-alpha-synuclein antibodies and methods of use thereof |
2022-3-17 |
2022-5-01 |
|
| Anti-transferrin receptor fusion proteins and methods of use thereof |
2022-2-11 |
2022-8-18 |
|
| Compounds, compositions and methods |
2022-2-01 |
2022-5-19 |
|
| Compound, compositions, and methods |
2021-12-29 |
2022-4-21 |
|
| Solid forms of a compound |
2021-12-17 |
2022-6-23 |
|
| Modified release formulation of a pyrimidinylamino-pyrazole compound, and … |
2021-11-25 |
2022-1-01 |
|
| Modulators of eukaryotic initiation factor 2B, compositions and methods |
2021-11-19 |
2022-12-29 |
|
| Compounds, compositions, and methods |
2021-11-19 |
2022-10-01 |
|
| Compounds, compositions and methods |
2021-11-02 |
2022-1-25 |
|
| Kinase Inhibitors and Uses Thereof |
2021-10-26 |
2022-2-10 |
|
| Methods for treating and monitoring frontotemporal dementia |
2021-10-13 |
2022-4-21 |
|
| Compounds, compositions and methods |
2021-10-10 |
2021-12-01 |
|
| Engineered transferrin receptor binding polypeptides |
2021-9-27 |
2021-10-28 |
|
| Anti-trem2 antibodies and methods of using them |
2021-9-17 |
2021-9-30 |
|
| Anti-apoe antibodies |
2021-8-24 |
2022-12-29 |
|
| Compounds, compositions and methods |
2021-8-13 |
2022-6-01 |
|
| COMPOUNDS, COMPOSITIONS AND METHODS |
2021-8-13 |
2022-11-16 |
|
| Compounds, compositions and methods |
2021-8-10 |
2021-8-30 |
|
| Compounds, compositions and methods |
2021-7-01 |
2023-3-24 |
|
| Substituted pyrimidines as lrkk2 inhibitors |
2021-6-07 |
2021-9-30 |
|
| Engineered anti-HER2 bispecific proteins |
2021-2-19 |
2023-4-05 |
|
| Anti-her2 polypeptides and methods of use thereof |
2021-2-18 |
2022-1-06 |
|
| Engineered bispecific proteins |
2021-2-15 |
2021-4-29 |
|
| Methods for the treatment of hunter syndrome |
2021-2-05 |
2023-3-23 |
|
| ANTI-TREM2 ANTIBODIES AND METHODS OF USING THEM |
2021-1-13 |
2022-4-13 |
|
| PROGRANULIN VARIANTS |
2020-12-23 |
2022-3-30 |
|
| FUSION PROTEINS INCLUDING PROGRANULIN |
2020-12-16 |
2021-1-29 |
|
| Polymorphs and solid forms of a pyrimidinylamino-pyrazole compound, and methods … |
2020-11-27 |
2021-3-25 |
|
| Fusion proteins comprising enzyme replacement therapy enzymes |
2020-11-23 |
2021-7-01 |
|
| Transferrin receptor binding polypeptides and uses of these. |
2020-8-10 |
2020-10-30 |
|
| Process for the preparation of pyrimidinyl-4-aminopyrazole compounds |
2020-6-18 |
2020-8-31 |
|
| Anti-bace1 antibodies and methods of use thereof |
2020-5-06 |
2021-3-11 |
|
| Formulations of protein molecules comprising iduronate 2-sulfatase |
2020-4-03 |
2020-10-08 |
|
| Compounds, compositions and methods |
2020-3-06 |
2020-9-10 |
|
| ANTI-TRAIN2 ANTIBODIES AND METHODS OF USE THEREOF |
2020-2-20 |
2021-10-05 |
|
| COMPOUNDS, COMPOSITIONS AND METHODS |
2020-2-13 |
2021-9-15 |
|
| Compounds, compositions and methods |
2020-2-12 |
2021-12-22 |
|
| COMPOUNDS, COMPOSITIONS AND METHODS |
2020-2-12 |
2021-10-05 |
|
| Affinity-based methods for using transferrin receptor-binding proteins |
2020-2-05 |
2020-9-17 |
|
| Lysosomal storage disorder biomarkers and methods of use thereof |
2019-12-10 |
2021-10-20 |
|
| Methods for treating dysregulated lipid metabolism |
2019-11-26 |
2021-10-06 |
|
| KINASE INHIBITORS AND USE OF THEM |
2019-11-01 |
2021-6-30 |
|
| Methods for treating and monitoring progranulin-associated disorders |
2019-10-15 |
2021-12-23 |
|
| Tool Coating Processing Method |
2019-9-30 |
2022-8-04 |
|
| Engineered polypeptides |
2019-9-17 |
2020-8-20 |
|
| Anti-tau antibodies and methods of use thereof |
2019-8-16 |
2020-7-09 |
|
| Polynucleotides encoding chimeric transferrin receptor polypeptides, host cells … |
2019-8-12 |
2019-10-31 |
|
| AZEPINES AND CONDENSED OXAZEPINES AS PROTEIN KINASE 1 INHIBITORS, THE … |
2019-7-12 |
2021-2-24 |
|
| FUSION PROTEINS INCLUDING PROGRANULIN |
2019-6-18 |
2021-2-03 |
|
| Modulators of eukaryotic initiation factor 2 |
2019-3-22 |
2021-5-06 |
|
| Bace-tau bispecific antibodies |
2018-11-08 |
2019-5-16 |
|
| Transferrin receptor transgenic models |
2018-10-19 |
2019-9-12 |
|
| FUSION PROTEINS INCLUDING ENZYME REPLACEMENT THERAPY (ERT) ENZYMES AND A FC … |
2018-10-01 |
2020-4-22 |
|
| Anti-trem2 antibodies and methods of use thereof |
2018-9-14 |
2019-3-21 |
|
| Compounds, compositions and methods |
2018-8-31 |
2019-3-07 |
|
| COMPOUNDS, COMPOSITIONS AND METHODS |
2018-8-31 |
2022-3-02 |
|
| MODULATORS OF THE EUCHARYOTIC INITIATION FACTOR 2B |
2018-8-09 |
2019-10-30 |
|
| Inhibitors of receptor?interacting protein kinase 1 |
2018-7-18 |
2022-9-15 |
2022-9-15 |
| Anti-alpha-synuclein antibodies and methods of use thereof |
2018-6-22 |
2018-12-27 |
|
| Phospho-rab antibodies, assays and methods of use thereof |
2018-6-15 |
2019-2-07 |
|
| MODIFIED TRANSFERRIN RECEIVER BINDING POLYPEPTIDES |
2018-2-15 |
2019-12-25 |
|
| Engineered polypeptides |
2018-2-15 |
2019-12-25 |
|
| ANTI-TAU ANTIBODIES AND METHODS OF USE OF THE SAME |
2018-2-15 |
2019-5-22 |
|
| Compounds, compositions and methods |
2017-12-08 |
2023-3-31 |
2023-3-31 |
| 化合物、組成物、及び、方法 |
2022-12-28 |
2023-4-11 |
|
| 操作された抗ｈｅｒ２二重特異性タンパク質 |
2021-2-19 |
2023-4-05 |
|
| Anticorpos anti-trem2 e métodos de uso dos mesmos |
2020-2-20 |
2021-10-05 |
|
| Compostos, composições e métodos |
2020-2-12 |
2021-10-05 |
|